Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of OC000459 in Healthy Subjects
NCT02341521Phase 1Completed
- Sponsor
- Atopix Therapeutics
- Start
- Mar 2015
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of timapiprant in asthma, sponsored by Atopix Therapeutics. Primary endpoint: Metabolite Pharmacokinetics at Day 8. Started Mar 2015; status: completed.
02
Drugs
timapiprant
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02341521.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02341521.